Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

NCT02441933 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

878

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: taxane plus carboplatin
DRUG: Taxane

Sponsor

Yonsei University